Japanese firms Mitsui & Co and Rohto Pharmaceutical have agreed to jointly acquire the Eu Yan Sang International (EYS), a 140-year-old Singapore company that retails traditional Chinese medicines. The deal values EYS at S$800 million ($593 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
